ICCM Stock Analysis: Buy, Sell, or Hold?
ICCM - IceCure Medical Ltd. Ordinary Shares
$5.36
0.08 (1.52%)
▲
5d:
-23.65%
30d:
+3756.12%
90d:
+1680.73%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When ICCM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ICCM shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ICCM shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: ICCM is currently trading at $5.36, which is considered extended relative to its 30-day fair value range of $0.06 to $5.41. From a valuation perspective, the stock is trading at a discount (Forward PE: -1.4) compared to its historical average (7.5). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ICCM is in a downtrend. Immediate support is located at $0.12, while resistance sits at $5.69.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.50 (+469.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ICCM is in a downtrend. Immediate support is located at $0.12, while resistance sits at $5.69.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.50 (+469.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.06 -
$5.41
Company Quality Score
54/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
51.0%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: Trading 469.0% below Wall St target ($30.50)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: 5-day price weakness (-23.6%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.06 -
$5.41
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.13
Resistance Level
$5.69
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.38
Wall Street Target
$30.50
(+469.0%)
Revenue Growth (YoY)
25.7%
PE vs Historical
-1.4 vs 7.5
CHEAP
Share & Embed Analysis
Last updated: July 02, 2026 10:50 PM ET
Data refreshes hourly during market hours. Next update: 11:50 PM
Data refreshes hourly during market hours. Next update: 11:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICCM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |
